Drug intelligence / Profile preview

Om-Sip

Development stage: Unknown
Lead developer: Alico Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Om-Sip is an oral iron supplement marketed as a nutraceutical by Alico Pharmaceutical. It is designed to provide supplemental iron to the body, which is essential for the synthesis of hemoglobin and the transport of oxygen in the blood. The product is listed in Alico's consumer health catalog as an over-the-counter dietary supplement rather than a prescription pharmaceutical or clinical-stage drug candidate.

Brand names: Om-Sip
Other names: Iron

Beyond the preview

Go deeper on Om-Sip.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Om-Sip.

Explore the full profile